Testing the Anesthetic Effectiveness of Buffered Articaine Injected Next to a Lower First Molar.
Study Details
Study Description
Brief Summary
Infiltration (injecting next to the tooth) injections are common in dentistry and a number of studies have shown that articaine anesthetic, when injected next to a lower molar, is more effective than a local anesthetic injection of lidocaine. However success rates have not been as high as hoped for. No objective study has addressed the success rate of buffering articaine in a mandibular primary buccal infiltration of the first molar. Therefore, the purpose of this prospective, randomized, double-blind, crossover study is to compare the degree of pulpal anesthesia obtained with a buffered 4% articaine with 1:100,000 epinephrine solution versus a non-buffered 4% articaine with 1:100,000 epinephrine solution as a primary infiltration in the mandibular first molar. The investigators will also record the pain of injection and postoperative pain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
Using a crossover design, 80 adult subjects will receive two injections consisting of a primary mandibular first molar infiltration of 1.8 mL of non-buffered 4% articaine with 1:100,000 epinephrine, and 1.8 mL of buffered 4% articaine with 1:100,000 in two separate appointments spaced at least one week apart. With the crossover design, 160 infiltrations will be given for the first molar and each subject will serve as his or her own control. Eighty infiltrations will be administered on the mandibular left side and 80 administered on the mandibular right side. The order of the two injections will be assigned randomly and the dentist and subject will be blinded about which anesthetic the subject is given. The anesthetics used in this study are not experimental. An electric pulp tester (EPT) will be used to test the lower first molar for anesthesia starting 30 seconds after the injection; and testing every 30 seconds for the first five minutes. After five minutes the EPT will be used to test the lower first molar every minute and the contralateral control canine every 5 minutes for a grand total of sixty minutes. The pain of injection and postoperative pain will be recorded in a survey. Patients will report any postoperative pain or discomfort on a Visual Analog Scale (VAS) for three days following each appointment. The data will be statistically analyzed.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Buffered Articaine at 1st Appointment Subjects received an infiltration injection of 1.8cc buffered 4% articaine. |
Drug: Buffered Articaine Hydrochloride + Epinephrine
|
Active Comparator: Articaine at 1st Appointment Subjects received an infiltration injection of 1.8cc 4% articaine (unbuffered). |
Drug: Articaine Hydrochloride + Epinephrine
|
Outcome Measures
Primary Outcome Measures
- Number of Participants Achieving Pulpal Anesthesia. [60 minutes per injection sequence.]
An electric pulp tester will be used to test the lower jaw teeth (molars, premolars, and incisors) for anesthesia (numbness) in 4-minute time cycles for 60 minutes. Measurements of less than 80 on the EPT is considered not numb (anesthesia failure). Readings of 80 equate to anesthetic success.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Between the age of 18-65 years.
-
in good health (ASA classification II or higher).
-
able to provide informed consent.
Exclusion Criteria:
-
allergy to articaine.
-
history of significant medical problems (ASA classification of III or worse).
-
diagnosed depression (taking tri-cyclic antidepressant medications to control).
-
have taken central nervous system (CNS) depressants (including alcohol or any analgesic medications) within the last 48 hours prior to testing.
-
lactating or pregnant.
-
inability to give informed consent.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The Ohio State University College of Dentistry, Postle Hall | Columbus | Ohio | United States | 43210 |
Sponsors and Collaborators
- Ohio State University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- Abdulwahab M, Boynes S, Moore P, Seifikar S, Al-Jazzaf A, Alshuraidah A, Zovko J, Close J. The efficacy of six local anesthetic formulations used for posterior mandibular buccal infiltration anesthesia. J Am Dent Assoc. 2009 Aug;140(8):1018-24.
- Burmeister CH. A practical method for the extemporaneous preparations of a buffered anesthetic solution. J Am Dent Assoc 22:1514, 1935.
- Corbett IP, Kanaa MD, Whitworth JM, Meechan JG. Articaine infiltration for anesthesia of mandibular first molars. J Endod. 2008 May;34(5):514-8. doi: 10.1016/j.joen.2008.02.042.
- Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine and lidocaine mandibular buccal infiltration anesthesia: a prospective randomized double-blind cross-over study. J Endod. 2006 Apr;32(4):296-8. Epub 2006 Feb 17.
- Robertson D, Nusstein J, Reader A, Beck M, McCartney M. The anesthetic efficacy of articaine in buccal infiltration of mandibular posterior teeth. J Am Dent Assoc. 2007 Aug;138(8):1104-12.
- Sinnott CJ, Garfield JM, Thalhammer JG, Strichartz GR. Addition of sodium bicarbonate to lidocaine decreases the duration of peripheral nerve block in the rat. Anesthesiology. 2000 Oct;93(4):1045-52.
- Buffered Articaine
Study Results
Participant Flow
Recruitment Details | 80 subjects will be recruited in this crossover study. Each of the subjects will receive the injection regimens at 2 separate appointments spaced at least 2 weeks apart. |
---|---|
Pre-assignment Detail |
Arm/Group Title | Articaine (First) | Buffered Articaine (First) |
---|---|---|
Arm/Group Description | Subjects receiving 1.8cc articaine injection at first appointment. | Subjects receiving injection of 1.8cc buffered articaine at first appointment. |
Period Title: First Appointment. | ||
STARTED | 40 | 40 |
COMPLETED | 40 | 40 |
NOT COMPLETED | 0 | 0 |
Period Title: First Appointment. | ||
STARTED | 40 | 40 |
COMPLETED | 40 | 40 |
NOT COMPLETED | 0 | 0 |
Period Title: First Appointment. | ||
STARTED | 40 | 40 |
COMPLETED | 40 | 40 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Articaine |
---|---|
Arm/Group Description | Subjects receiving articaine injection. |
Overall Participants | 80 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
80
100%
|
>=65 years |
0
0%
|
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
25.3
(2.5)
|
Sex: Female, Male (Count of Participants) | |
Female |
38
47.5%
|
Male |
42
52.5%
|
Region of Enrollment (Count of Participants) | |
United States |
80
100%
|
Outcome Measures
Title | Number of Participants Achieving Pulpal Anesthesia. |
---|---|
Description | An electric pulp tester will be used to test the lower jaw teeth (molars, premolars, and incisors) for anesthesia (numbness) in 4-minute time cycles for 60 minutes. Measurements of less than 80 on the EPT is considered not numb (anesthesia failure). Readings of 80 equate to anesthetic success. |
Time Frame | 60 minutes per injection sequence. |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Articaine | Buffered Articaine |
---|---|---|
Arm/Group Description | Subjects receiving articaine injection. | Subjects receiving an injection of 1.8cc buffered articaine. |
Measure Participants | 80 | 80 |
Count of Participants [Participants] |
52
65%
|
57
NaN
|
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Articaine | Buffered Articaine | ||
Arm/Group Description | Subjects receiving injection of 1.8cc 4% articaine. | Subjects receiving injection of 1.8cc buffered 4% articaine. | ||
All Cause Mortality |
||||
Articaine | Buffered Articaine | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Articaine | Buffered Articaine | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/80 (0%) | 0/80 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Articaine | Buffered Articaine | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/80 (0%) | 0/80 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. John Nusstein, Professor |
---|---|
Organization | The Ohio State University College of Dentistry |
Phone | 614-292-3596 |
nusstein.1@osu.edu |
- Buffered Articaine